Filtrar por Last updated date SelectDespués deAntes deFrom - To Fecha Fecha de final Esta semana Este mes la semana pasada El mes pasado Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationMedical devicesScientific adviceMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Deje este campo en blanco Filter Resultados (3794) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Deje este campo en blanco COVID-19: EMA recommends authorisation of two monoclonal antibody medicines 12 Noviembre 2021 News Human COVID-19 Medicines Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 8-11 November 2021 12 Noviembre 2021 News Human COVID-19 Medicines First-in-class medicine recommended for treatment of rare blood vessel inflammation 12 Noviembre 2021 News Human Medicines EMA starts evaluating use of COVID-19 vaccine Spikevax in children aged 6 to 11 10 Noviembre 2021 News Human COVID-19 Vaccines COVID-19: EMA and Heads of Medicines Agencies update on molnupiravir 8 Noviembre 2021 News Human COVID-19 Medicines Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 3-4 November 2021 8 Noviembre 2021 News Veterinary Medicines EMA ends rolling review of the antibodies bamlanivimab and etesevimab for COVID-19 following withdrawal by Lilly 2 Noviembre 2021 News Human COVID-19 Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 25-28 October 2021 29 Octubre 2021 News Human COVID-19 Pharmacovigilance Referrals Vaccines Regulatory update - EMA encourages companies to submit type I variations for 2021 in November 2021 29 Octubre 2021 News Human Veterinary Repurposing of authorised medicines: pilot to support not-for-profit organisations and academia 28 Octubre 2021 News Human Regulatory and procedural guidance Scientific advice 1 … 51 52 53 54 55 Page 55 of 380 56 57 58 59 … 380
COVID-19: EMA recommends authorisation of two monoclonal antibody medicines 12 Noviembre 2021 News Human COVID-19 Medicines
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 8-11 November 2021 12 Noviembre 2021 News Human COVID-19 Medicines
First-in-class medicine recommended for treatment of rare blood vessel inflammation 12 Noviembre 2021 News Human Medicines
EMA starts evaluating use of COVID-19 vaccine Spikevax in children aged 6 to 11 10 Noviembre 2021 News Human COVID-19 Vaccines
COVID-19: EMA and Heads of Medicines Agencies update on molnupiravir 8 Noviembre 2021 News Human COVID-19 Medicines
Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 3-4 November 2021 8 Noviembre 2021 News Veterinary Medicines
EMA ends rolling review of the antibodies bamlanivimab and etesevimab for COVID-19 following withdrawal by Lilly 2 Noviembre 2021 News Human COVID-19
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 25-28 October 2021 29 Octubre 2021 News Human COVID-19 Pharmacovigilance Referrals Vaccines
Regulatory update - EMA encourages companies to submit type I variations for 2021 in November 2021 29 Octubre 2021 News Human Veterinary
Repurposing of authorised medicines: pilot to support not-for-profit organisations and academia 28 Octubre 2021 News Human Regulatory and procedural guidance Scientific advice